Pulmonary lesions and clinical disease response to Mannheimia haemolytic a challenge 10 days following administration of tildipirosin or tulathromycin

Authors

  • D. E. Amrine Department of Clinical Sciences, Kansas State University, Manhattan, KS 66506
  • B. J. White Department of Clinical Sciences, Kansas State University, Manhattan, KS 66506
  • R. L. Larson Department of Clinical Sciences, Kansas State University, Manhattan, KS 66506
  • D. A. Mosier Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506

DOI:

https://doi.org/10.21423/aabppro20133813

Keywords:

BRD, bovine respiratory disease, beef cattle, MH, mannheimia haemolytica, pathogen, tildipirosin, tulathromycin

Abstract

Bovine respiratory disease (BRD) causes significant economic loss to the beef cattle industry. Mannheimia haemolytica (MH) is considered the predominant bacterial pathogen associated with BRD. The purpose of this randomized, blinded, controlled clinical trial was to evaluate the effect of metaphylactic administration of tildipirosin or tulathromycin 10 days prior to experimental inoculation with MH on the development of pulmonary lesions in beef heifers.

Cover image of the 46th Conference Proceedings: An image of cattle standing in a field during th day. They are looking rather indignantly at the camera. Yellow background.

Downloads

Published

2013-09-19

Issue

2013

Section

Research Summaries 1

Most read articles by the same author(s)

1 2 3 4 > >>